Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Left bundle branch pacing plus ivabradine in chronic heart failure with atrial fibrillation
ChiCTR2500108618Phase 4Recruiting
- Sponsor
- Peking University International Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ivabradine in chronic heart failure (CHF) and Atrial fibrillation (AFib) (2 arms), sponsored by Peking University International Hospital. Primary endpoints: ventricular pacing ratio and echocardiographic indicators. Started Sep 2025; status: recruiting.
02
Drugs
ivabradine
03
Conditions
chronic heart failure (CHF)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2500108618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108618.